Patent details

Basic Information

Publication number:

EP3632919

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP191921428

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOISITIONS COMPRISING IMIDAZOTHIADIAZOLE AND IMIDAZOPYRIDAZINE DERIVATIVES AS PROTEASE ACTIVATED RECEPTOR 4 (PAR4) INHIBITORS FOR TREATING PLATELET AGGREGATION

French Title of Invention:

COMPOSITIONS PHARMACEUTIQUES COMPRENANT DES DÉRIVÉS D'IMIDAZOTHIADIAZOLE ET D'IMIDAZOPYRIDAZINE UTILISÉS COMME INHIBITEURS DU RÉCEPTEUR 4 ACTIVÉ PAR UNE PROTÉASE (PAR4) POUR LE TRAITEMENT DE L'AGRÉGATION PLAQUETTAIRE

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETUNGEN ENTHALTEND IMIDAZOTHIADIAZOL- UND IMIDAZOPYRIDAZINDERIVATE ALS PROTEASEAKTIVIERTE REZEPTOR 4 (PAR4)-INHIBITOREN ZUR BEHANDLUNG VON THROMBOZYTENAGGREGATION

SPC Number:

Dates

Filing date:

24/04/2013

Grant date:

26/10/2022

EP Publication Date:

08/04/2020

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/10/2022

EP B1 Publication Date:

26/10/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

24/04/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

19/10/2022

 

 

Name:

Bristol-Myers Squibb Company

Address:

Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)

Name:

Université de Montréal

Address:

2900 Boulevard Edouard-Montpetit, Montreal, QC H3T 1J4, Canada (CA)

Agent

Name:

MARKS & CLERK LLP

From:

29/12/2022

Address:

BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

1

Name:

DUBÉ, Laurence

Address:

Canada (CA)

2

Name:

MILLER, Michael M.

Address:

United States (US)

3

Name:

GAGNON, Marc

Address:

Canada (CA)

4

Name:

LAWRENCE, Michael R.

Address:

United States (US)

5

Name:

PRIESTLEY, Eldon Scott

Address:

United States (US)

6

Name:

BANVILLE, Jacques

Address:

Canada (CA)

7

Name:

RUEDIGER, Edward H.

Address:

Canada (CA)

8

Name:

POSY, Shoshana L.

Address:

United States (US)

9

Name:

DEON, Daniel H.

Address:

Canada (CA)

10

Name:

MAXWELL, Brad D.

Address:

United States (US)

11

Name:

RÉMILLARD, Roger

Address:

Canada (CA)

12

Name:

GUY, Julia

Address:

Canada (CA)

13

Name:

WONG, Pancras C.

Address:

United States (US)

Priority

1

Priority Number:

201261638577 P

Priority Date:

26/04/2012

Priority Country:

United States (US)

2

Priority Number:

201361787680 P

Priority Date:

15/03/2013

Priority Country:

United States (US)

Classification

IPC classification:

C07D 519/00; A61K 31/433; C07D 513/04; A61K 31/5025; C07D 487/04; A61K 31/4355; A61P 7/02;

Publication

European Patent Bulletin

Issue number:

202243

Publication date:

26/10/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

30/04/2025

Annual Fee Number:

13

Annual Fee Amount:

180 Euro

Expected Payer:

Last Annual Fee Payment Date:

11/04/2024

Last Annual Fee Paid Number:

12

Last Annual Fee Paid Amount:

165 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
29/12/2022	Power Of Attorney	1
29/12/2022	Outgoing Correspondence	1